Conmed (CNMD) Total Non-Current Liabilities (2010 - 2026)
Conmed's (CNMD) quarterly Total Non-Current Liabilities came in at $1.2 billion in Q2 2026, down 3.91% YoY from $1.2 billion in Q2 2025, and down 3.02% on a QoQ basis from $1.2 billion in Q1 2026.
Conmed (CNMD) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Conmed (CNMD) has 17 years of Total Non-Current Liabilities data on file, last reported at $1.2 billion in Q2 2026.
- Quarterly Total Non-Current Liabilities fell 3.91% year-over-year to $1.2 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.2 billion (down 3.91% YoY) and the FY2025 annual result came in at $1.2 billion, down 2.26% from the prior year.
- Total Non-Current Liabilities declined to $1.2 billion in Q2 2026, from $1.2 billion in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $1.4 billion in Q2 2023 to a low of $954.4 million in Q1 2022.
- A 5-year average of $1.3 billion and a median of $1.3 billion in 2022 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2023 — Total Non-Current Liabilities soared 44.76% — and 2025, when it retreated 7.5%.
- Tracing CNMD's Total Non-Current Liabilities over 5 years: stood at $1.3 billion in 2022, then decreased by 0.27% to $1.3 billion in 2023, then dropped by 6.51% to $1.3 billion in 2024, then slipped by 2.26% to $1.2 billion in 2025, then retreated by 2.59% to $1.2 billion in 2026.
- The last three Total Non-Current Liabilities figures came in at $1.2 billion (Q2 2026), $1.2 billion (Q1 2026), and $1.2 billion (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Conmed | 1.54 Bn | 1.50 Bn | 197.46 Mn | 1.20 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.20 Bn |
| Mar 31, 2026 | 1.23 Bn |
| Dec 31, 2025 | 1.23 Bn |
| Sep 30, 2025 | 1.24 Bn |
| Jun 30, 2025 | 1.25 Bn |
| Mar 31, 2025 | 1.24 Bn |
| Dec 31, 2024 | 1.26 Bn |
| Sep 30, 2024 | 1.29 Bn |
| Jun 30, 2024 | 1.30 Bn |
| Mar 31, 2024 | 1.35 Bn |
| Dec 31, 2023 | 1.34 Bn |
| Sep 30, 2023 | 1.39 Bn |
| Jun 30, 2023 | 1.39 Bn |
| Mar 31, 2023 | 1.38 Bn |
| Dec 31, 2022 | 1.35 Bn |
| Sep 30, 2022 | 1.36 Bn |
| Jun 30, 2022 | 1.29 Bn |
| Mar 31, 2022 | 954.37 Mn |
| Dec 31, 2021 | 937.59 Mn |
| Sep 30, 2021 | 945.47 Mn |